OyenugaAFolsomARFashanuOAguilarDBallantyneCM. Plasma galectin-3 and sonographic measures of carotid atherosclerosis in the atherosclerosis risk in communities study. Angiology. 2019;70:47–55.
2.
BoutsikouTGiotakiMBoutsikouM, et al.Cord blood galectin-1 and -3 concentrations in term pregnancies with normal, restricted and increased fetal growth. J Perinat Med. 2015;43:305–9.
3.
NewlaczylAUYuLG. Galectin-3—a jack-of-all-trades in cancer. Cancer Lett. 2011;313:123–28.
4.
LiuFTRabinovichGA. Galectins as modulators of tumour progression. Nat Rev Cancer. 2005;5:29–41.
5.
YorulmazHOzkokEKaptanEAtesGTamerS. Therapeutic effects of simvastatin on Galectin-3 and oxidative stress parameters in endotoxemic lung tissue. Biosci Rep. 2018;38:pii:BSR20180308.
6.
ParaskevasKIStathopoulosVMikhailidisDP. Pleiotropic effects of statins: implications for a wide range of diseases. Curr Vasc Pharmacol. 2008;6:237–39.
7.
ParaskevasKITzovarasAABrianaDDMikhailidisDP. Emerging indications for statins: a pluripotent family of agents with several potential applications. Curr Pharm Des. 2007;13:3622–36.
8.
ParaskevasKIAthyrosVGBrianaDDMikhailidisDPKakafikaAIKaragiannisA. Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Curr Drug Targets. 2007;8:942–51.
